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The objective of the present study was to develop the selection criteria of proton signals for
the determination of scutellarin using quantitative nuclear magnetic resonance (qNMR),
which is the main bioactive compound in breviscapine preparations for the treatment of
cerebrovascular disease. The methyl singlet signal of 3-(trimethylsilyl)propionic-2,2,3,3-d4
acid sodium salt was selected as the internal standard for quantification. The molar con-
centration of scutellarin was determined by employing different proton signals. To obtain
optimum proton signals for the quantification, different combinations of proton signals
were investigated according to two selection criteria: the recovery rate of qNMR method
and quantitative results compared with those obtained with ultra-performance liquid
chromatography. As a result, the chemical shift of H-20 and H-60 at d 7.88 was demonstrated
as the most suitable signal with excellent linearity range, precision, and recovery for
determining scutellarin in breviscapine preparations from different manufacturers, batch
numbers, and dosage forms. Hierarchical cluster analysis was employed to evaluate the
determination results. The results demonstrated that the selection criteria of proton sig-
nals established in this work were reliable for the qNMR study of scutellarin in brevisca-
pine preparations.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
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Proton nuclear magnetic resonance (1H-NMR) spectroscopy
has been widely applied to the structural elucidation of
organic compounds. With the popularity and promotion of
the high-resolution nuclear magnetic spectrometer [1], 1H-
NMR has been extensively applied in the qualitative [2] and
quantitative [3] analysis of traditional Chinese medicine.
Compared with high-performance liquid chromatography
(HPLC) [4], 1H-NMR has characteristics of being nondestruc-
tive, nonselective, high-speed, and free of standards. With
the maturity and development of the quantitative nuclear
magnetic resonance (qNMR) technology, considerable
studies have been reported. For example, Rodrigues et al [5]
established the partial least squares NMR method, which
was a good choice for the determination of organic acid in
beer. Dais and Hatzakis [6] summarized that NMR spectros-
copy had been extensively used for the analysis of olive oil,
which proved a valuable tool to assess the quality and
authenticity of olive oil. Pan et al [7] presented an exploratory
study for monitoring the hydrolytic process of salvianolic
acid B in low oxygen conditions using a simple qNMR
method. However, in previous studies, the selection criteria
of the proton signal for quantitation using qNMR was not
systematically studied, although it is vital for the feasibility
of a validated qNMR method [8].
Breviscapine preparations have been recorded by the State
Food and Drug Administration as a traditional Chinese med-
icine [9]. Scutellarin is the main active component in bre-
viscapine preparations, which have been used for the
treatment of cerebrovascular disease [10], including car-
diomyocytes injuries [10], focal cerebral ischemia [11], and
hemiplegia [12]. The quantitative analysis of scutellarin using
HPLC with photodiode array detector (HPLC-DAD) [13] and
liquid chromatography-tandem mass spectrometry [12] has
been reported. However, these methods have some limita-
tions, such as the need of reference substances, long analysis
times, and the consumption of organic solvents.
In this study, a rapid, sensitive, and reliable qNMRmethod
combined with proton signal selection criteria was estab-
lished to accurately determine scutellarin in breviscapine
preparations. The detailed steps of this qNMRmethodwere as
follows: (1) to identify scutellarin using 1H-NMR and confirm
the characteristic proton signals (1H, 2H, and 3H) without
interference; (2) to determine scutellarin by using the char-
acteristic proton signals or their combinations (1H, 2H, 3H,
1Hþ2H, 1Hþ3H, 2Hþ3H, and 1Hþ2Hþ3H); (3) to choose the
optimum quantitative proton signal or combination accord-
ing to two selection criteria: the recovery rate of qNMR
method and the quantification results compared with those
obtained by ultra-performance liquid chromatography
(UPLC); (4) to determine different manufacturers, different
batch numbers, and different dosage forms of breviscapine
preparations by using the optimal proton signal; and (5) to
statistically analyze the quantitative results. The results
indicated that the qNMR method established in this work
could be successfully used for the quality control of bre-
viscapine preparations.2. Methods
2.1. Reagents and materials
Deuterium oxide (D2O, 99.9%), 3-(trimethylsilyl)propionic-
2,2,3,3-d4 acid sodium salt (TSP-d4, 98% deuterated), methanol,
and acetonitrile were purchased from Sigma (Sigma-Aldrich,
St. Louis, MO, USA). Dimethyl sulfoxide-d6 (DMSO-d6, 99.9%
deuterated) was obtained from Cambridge Isotope Labora-
tories, Inc. (CIL Inc., Andover, MA, USA). DMSO was acquired
from Solarbio Technology Co., Ltd (Beijing, China). Ultra-pure
water used in the experiments was purified by a Milli-Q sys-
tem (Millipore, Billerica, MA, USA).
The reference of scutellarin was purchased from Chengdu
Pufeide Biotech Co., Ltd (Szechwan, China). The purity of the
standard was above 98%.
Tablets were obtained from Yunnan Bio Valley Pharma-
ceutical Co., Ltd (Yunnan, China), Yunnan Bio Valley Long-
kang Pharmaceutical Co., Ltd (Yunnan, China, commissioned
production by Yunnan Bio Valley Pharmaceutical Co., Ltd),
Yunnan Baiyao Group XingZhong Pharmaceutical Co., Ltd
(Yunnan, China), and Yunnan Rainbow Pharmaceutical Group
Yuxi Pharmaceutical Co., Ltd (Yunnan, China). Tablets were
labeled as T-BV, T-BVLK-1, T-BVLK-2, T-XZ-1, T-XZ-2, T-YX-1,
or T-YX-2, respectively. The injectable form was purchased
from ShiYao YinHu Pharmaceuticals Co., Ltd (Shanxi, China)
and was designated as I-SY.2.2. Preparation of standard solutions and the internal
standard solution
For NMR analysis, scutellarin was accurately weighed and
dissolved in DMSO-d6 to obtain a working solution at a final
concentration of 5.75 mg/mL. The internal standard (IS) stock
solution was prepared by dissolving TSP-d4 in D2O, which was
then diluted with D2O to obtain a final concentration of
0.01 %(g/mL).
For LC analysis, the stock solution of scutellarin dissolved
in DMSO (1.002mg/mL) was used to prepare working standard
solutions by serial dilution with methanol.2.3. Sample preparation
For the NMR experiment, breviscapine tablets were pulverized
to powders. The powder (20.0mg) was accurately weighed in a
2-mL volumetric flask and was dissolved with DMSO-d6 to the
volume and labeled “tablet solution”. Subsequently, 1 mL of
the tablet solution was transferred to another 2-mL volu-
metric flask and dilutedwith the IS solution to the volume. For
breviscapine injection, 1mL of the samplewas directly diluted
with IS solution in a 2-mL volumetric flask. Finally, 0.6 mL of
each sample solution was transferred to a 5-mm NMR tube
and sealed for 1H-NMR and carbon-13 NMR experiments.
For the UPLC experiment, powdered breviscapine (10.0 mg)
was accurately weighed in a 25-mL volumetric flask and dis-
solved with methanol to the volume. For breviscapine injec-
tion, 1mL of the sample was directly diluted withmethanol in
Figure 1 e Proton nuclear magnetic resonance spectra of
breviscapine tablets in (A) dimethyl sulfoxide DMSO-d6 and
(B) DMSO-d6 þ deuterium oxide.
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vortex-mixed uniformly and filtered through a 0.45-mm filter.2.4. NMR conditions
The NMR experiment was performed on a Bruker AVIII-600
NMR spectrometer (Bruker, Zurich, Switzerland). 1H-NMRTable 1 e The linearity, precision, repeatability, and stability o
performance liquid chromatography (UPLC).
Proton signala Regression equation R2 Precision RSDs (%)
Intra-d Inter-d M
1H Y ¼ 0.7875X e 0.0025 0.9996 1.0 1.6
2H Y ¼ 0.7411X þ 0.0087 0.9998 1.8 2.5
3H Y ¼ 0.7675X þ 0.0032 0.9998 1.4 2.2
1Hþ2H Y ¼ 0.7643X þ 0.0031 0.9998 1.1 1.8
1Hþ3H Y ¼ 0.7775X þ 0.0003 0.9997 1.0 1.7
2Hþ3H Y ¼ 0.7543X þ 0.0059 0.9998 1.5 2.2
1Hþ2Hþ3H Y ¼ 0.7654X þ 0.0031 0.9998 1.1 1.9
RSDs ¼ relative standard deviations.
a 1H represented one proton (H-3) with a singlet peak at d 6.69, 2H repre
represented three protons with peaks in the range of d 6.96e6.98 (H-30,spectra were acquired using a zgcppr sequence at 298.6 K,
12335.5 Hz spectral width, 13-ms pulse width, 16 scans per
increment, 203 receiver gain, 2.7 seconds acquisition time,
and 15 seconds relaxation delay. The parameters of the two-
dimensional NMR, including correlation spectroscopy and
heteronuclear multiple bond correlation were established
according to a published method [14].
2.5. UPLC conditions
UPLC analysis was carried out on a Waters ACQUITY UPLC
system (Waters, Milford, CT, USA) equipped with a binary
solvent manager, sample manager, column oven, and diode-
array detector (DAD). Chromatographic separation was per-
formed on an ACQUITY UPLC BEH C18 column
(2.1 mm  100 mm, 1.7 mm) held at 40C. The detection
wavelength of the DADwas 335 nm. The flow rate was 0.4 mL/
min and the injection volume was 2 mL. Isocratic elution was
employed with a mobile phase composition of 0.1% formic
acid aqueous solution and acetonitrile (85:15).3. Results and Discussion
3.1. 1H-NMR characterization of scutellarin
The 1H-NMR spectra of scutellarin in breviscapine tablet are
shown in Figure 1. In DMSO-d6, the signals of four aromatic
protons at d 6.98 (2H, d, J ¼ 9.0 Hz) and 7.93 (2H, d, J ¼ 9.0 Hz)
were assigned to a 1,4-disubstituted benzene ring. The other
signals of two aromatic protons at d 6.82 (1H, s) and 6.99 (1H, s)
were assigned to H-3 and H-8 of the flavone. The signals at
d 5.22 (1H, d, J¼ 7.2 Hz) and 4.05 (1H, d, J¼ 9.6 Hz) indicated the
presence of a glucuronyl moiety. The anomeric configuration
was assigned as b for glucuronic acid from the coupling con-
stant (J¼ 7.2 Hz). The signals at d 8.59 (1H, br s), 10.36 (1H, br s),
and 12.74 (1H, br s) were assigned to OH-6, OH-40, and OH-5,
respectively, and these signals disappeared when D2O was
added to the percentage concentration of 50% (Figure 1B).
Furthermore, the chemical shift of H-20,60, H-30,50, H-8, and H-3
varied from d 7.93 to 7.88, 6.98 to 6.97, 6.99 to 6.96, and 6.82 to
6.69, respectively in DMSO-d6 and D2O solvent. The assign-
ment was further confirmed using carbon-13 NMR,f the different proton signals and the result of ultra-
Repeatability Stability RSDs (%) UPLC
Mean % (mg/mg)ean %(mg/mg) RSDs (%)
28.13 1.9 0.8 28.48
28.25 2.8 1.5
29.44 2.2 1.7
28.19 1.9 1.0
28.79 2.0 1.1
28.85 2.2 1.3
28.61 1.9 1.0
sented two protons (H-20, H-60) with doublet peaks at d 7.88, and 3H
H-50, and H-8).
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multiple bond correlation experiments. Consequently, the
structure of the compound was established as scutellarin
(Figure 1A).1
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t3.2. Optimization of IS selection
Many kinds of IS substances [15] could be used, such as TSP
[16], tetramethylsilane [17], 3,4-dimethylnitrobenzene, and
maleic acid [6]. The limitations of low boiling point and vola-
tility of tetramethylsilane could lead to unfavorable results
during quantitation. 3,4-dimethylnitrobenzene is relatively
stable but cannot be dissolved in water, which makes it un-
suitable for this study. The chemical shift of maleic acid is
d 6.44, which is too close to the signal of interest. Considering
the above shortcomings, TSP was selected. High-purity TSP
does not react with the samples or solvent. Furthermore, it
shows a sharp singlet peak at d 0, without interference from
other peaks (Figure 1). Therefore, TPS was the favorable IS for
calibration and quantitation in this study. Given the solubility
and response, TSP was dissolved in D2O to reach a final con-
centration of 0.01 %(g/mL).T
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).3.3. Methodological validation of the qNMR quantitative
analysis
All spectra were processed with phasing and baseline
correction. Three characteristic kinds of proton signals (1H,
2H, and 3H) without interference were selected to develop the
qNMR method in this work. The proton signal of 1H repre-
sented one proton (H-3) with a singlet peak at d 6.69. The
proton signal of 2H represented two protons (H-20, H-60) with
doublet peaks at d 7.88. The proton signal of 3H represented
three protonswith peaks in the range of d 6.96e6.98 (H-30, H-50,
and H-8). The content of scutellarin was calculated by the IS
method with different proton signals (1H, 2H, 3H) and their
combinations (1Hþ2H, 1Hþ3H, 2Hþ3H, 1Hþ2Hþ3H).
The molar concentration of scutellarin was calculated ac-
cording to the following equation:
CS ¼
A1H
N1H
þ A2HN2H þ
A3H
N3H
n
$
NIS
AIS
$CIS
CS, molar concentration of scutellarin; CIS, molar concen-
tration of TSP-d4; A1H, the integral area of 1H; A2H, the integral
area of 2H; A3H, the integral area of 3H; AIS: the integral area of
TSP-d4; N1H, the number of protons for 1H; N2H, the number of
protons for 2H; N3H, the number of protons for 3H; NIS, the
number of protons for TSP-d4; and n, the number of different
kinds of proton signals.
3.3.1. Repeatability, precision, stability, and recovery
Precision, repeatability, stability, and recovery were assessed
to validate the qNMR method, and the results of T-BV are
summarized in Tables 1 and 2. Intra- and inter-day variations
were employed to investigate the precision of the qNMR
method and all relative standard deviations (RSDs) of the
precisions did not exceed 2.5% (Table 1). A repeatability assay
was performed by analyzing six parallel samples twice, with
resulting RSDs below 2.8% (Table 1). The results demonstrated
Figure 2 e Box plot of the recovery obtained (A) by proton nuclear magnetic resonance and (B) scatter plot of the deviations of
scutellarin between proton nuclear magnetic resonance and ultra-performance liquid chromatography (UPLC).
qNMR ¼ quantitative nuclear magnetic resonance; ref. ¼ reference.
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quantitation of scutellarin. The stability was studied using the
same sample after 0 hours, 1 hour, 2 hours, 3 hours, 4 hours,
5 hours, and 6 hours, with resulting RSDs less than 1.7% (Table
1), which indicated that the sample solution was stable at
room temperature over 6 hours. Recovery assays were per-
formed by spiking the standard solution of scutellarin to six
parallel samples, respectively. The overall recoveries were in
the range of 93.70e99.91% with RSDs below 1.9% (Table 2 and
Figure 2).
3.3.2. Linearity
In this work, the IS method was applied to determine the
scutellarin while the linear dynamic ranges of NMR were
investigated to ensure quantitative results. A calibration curve
of scutellarin was constructed based on linear regression
analysis of the response (integral area ratio of scutellarin and
TSP-d4, Y) versus concentration (X) at five different concen-
trations in triplicate. All calibration curves were linear with
high correlation coefficients (R2  0.9996) over ranges of
0.18e2.88 mg/mL (shown in Table 1), which indicated that
different breviscapine preparations could be accurately
determined using the established qNMR method.3.4. UPLC quantitative analysis
In order to further evaluate the accuracy of the quantitative
results determined using qNMR, a UPLC method was
employed to quantify scutellarin. Specifically, a calibrationFigure 3 e Representative ultra-performance liquid
chromatography chromatogram of T-BV sample.
AU ¼ absorbance unit.curve was constructed at six different concentrations to
analyze the scutellarin content of T-BV, the typical chro-
matogram shown in Figure 3.3.5. Selection of optimum quantitative proton signal(s)
and sample analysis
The deviations of the quantitative results acquired from seven
kinds of proton signal and UPLC are shown in Figure 2. Obvi-
ously, the results of 2H, 1Hþ2H, and 1Hþ2Hþ3Hwere superior
to the others. Furthermore, the recovery assays demonstrated
that the results of 2H and 1Hþ2Hþ3H were more accurate. In
conclusion, 2H (d 7.88) was the optimum quantitative proton
signal and was consequently applied to the following
determination.
Eight batches of breviscapine preparations, including two
dosage forms from five different manufacturers, were deter-
mined with the established qNMR method using the proton
signal of 2H, the overlay NMR spectra shown in Figure 4. As
shown in Table 3, the percentage content of scutellarin in I-SY
was 405.89 %(mg/mL), which was significantly different from
the others. T-BV, T-BVLK-1, and T-BVLK-2; T-XZ-1 and T-XZ-2;
and T-YX-1 and T-YX-2 exhibited similar percentage contents
of scutellarin to each other.Figure 4 e The overlay nuclear magnetic resonance spectra
of all breviscapine preparations.
Table 3 e The percentage contents of scutellarin in
breviscapine preparations quantified using proton
nuclear magnetic resonance signals at d 7.88 (2H; n ¼ 3).
Sample Mean ± SD, %(mg/mg)
T-BV 28.25 ± 0.9
T-BVLK-1 30.07 ± 0.2
T-BVLK-2 28.56 ± 0.3
T-XZ-1 9.82 ± 0.2
T-XZ-2 9.98 ± 0.3
T-YX-1 13.57 ± 0.7
T-YX-2 13.95 ± 0.7
I-SYa 405.89 ± 8.1
SD ¼ standard deviation.
a Breviscapine injection %(mg/mL).
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HCA, a kind of unsupervised pattern recognition method, is
commonly used to classify samples into groups according to
their resemblance and difference of variable(s). To create a
dendrogram (Figure 5), Ward's method as the amalgamation
rule and the Euclidean distance as a measurement were
employed for HCA, which was processed using SPSS version
20.0 software (SPSS Inc., Chicago, IL, USA). As shown in
Figure 5A, eight breviscapine preparations were divided into
two groups. I-SY was categorized into Cluster I and the rest
into Cluster II, which was further sorted into twomain groups
(Cluster A and Cluster B) and two subgroups (Cluster A-1 and
Cluster A-2; Figure 5B). The HCA results visually revealed the
relationships between the samples. The percentage content
of scutellarin in I-SY was considerably higher than the other
samples. Therefore, I-SY was categorized into a group indi-
vidually (Cluster II) and far away from others, which indicated
that the percentage content of scutellarin was significantly
different in the two dosage forms. The percentage contents of
scutellarin in T-BV, T-BVLK-1, and T-BVLK-2 were similar and
two to three times higher than T-XZ-1, T-XZ-2, T-YX-1, and
T-YX-2, which were sorted into one group (Cluster B). T-XZ-1,Figure 5 e Dendrogram: (A) All breviscapine prT-XZ-2 T-YX-1, and T-YX-2 were further divided into two
subgroups. The results demonstrated that the percentage
contents of scutellarin were different (p < 0.05) between the
different manufacturers and forms, and such differences may
be ascribed to the different production technology and pro-
cesses of manufactures (especially for different forms) and
different origins, habitats, and harvest time of medicinal
herbs. Besides, the percentage contents of scutellarin from
the same pharmaceutical factory were fairly uniform
(p > 0.05) which could be attributed to the robust
manufacturing processes and dependable quality of
medicinal materials.
In this study, a methodology based on the qNMR method
combined with proton signal selection criteria was
developed for the determination of scutellarin in brevisca-
pine preparations. According to the recovery rate of qNMR
method and the qNMR quantification results compared with
those obtained by UPLC, the proton signal of 2H (d 7.88) was
selected to implement subsequent quantification analysis.
The data was further examined with HCA to intuitively
display the relationships between the breviscapine prepa-
rations from different manufacturers, with different batch
numbers, and as different dosage forms. As the results
show, the proposed qNMR methodology established in this
work was rapid, sensitive, and reliable, and may pave the
way for further quality assessment of breviscapine
preparations.Conflicts of interest
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